Hudson Bay Capital Management

Hudson Bay Capital Management Portfolio holdings

AUM $17.4B
1-Year Est. Return 27.36%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+27.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$16.4B
AUM Growth
+$1.23B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
1,353
New
Increased
Reduced
Closed

Top Buys

1
+$521M
2
+$212M
3
+$205M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$164M
5
TSM icon
TSMC
TSM
+$162M

Top Sells

1
+$272M
2
+$271M
3
+$206M
4
NVDA icon
NVIDIA
NVDA
+$186M
5
HES
Hess
HES
+$163M

Sector Composition

1 Technology 19.45%
2 Consumer Discretionary 16.47%
3 Financials 12.6%
4 Healthcare 7.25%
5 Real Estate 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCGA
601
Yorkville Acquisition Corp
MCGA
$239M
$1.6M 0.01%
+150,000
HNRG icon
602
Hallador Energy
HNRG
$886M
$1.56M 0.01%
79,549
-10,554
IPEX
603
Inflection Point Acquisition Corp V
IPEX
$123M
$1.54M 0.01%
150,000
-150,000
IR icon
604
Ingersoll Rand
IR
$37.6B
$1.53M 0.01%
+18,553
SLNO icon
605
Soleno Therapeutics
SLNO
$2.12B
$1.51M 0.01%
22,362
-44,990
ACAD icon
606
Acadia Pharmaceuticals
ACAD
$4.12B
$1.5M 0.01%
70,300
-119,700
GTERA
607
Globa Terra Acquisition Corp
GTERA
$237M
$1.5M 0.01%
+150,000
AXIN
608
Axiom Intelligence Acquisition Corp 1
AXIN
$276M
$1.5M 0.01%
+150,000
RDAG
609
Republic Digital Acquisition Co
RDAG
$383M
$1.5M 0.01%
146,580
XLK icon
610
State Street Technology Select Sector SPDR ETF
XLK
$88.4B
$1.49M 0.01%
+10,600
IMVT icon
611
Immunovant
IMVT
$5.37B
$1.49M 0.01%
92,500
MBX
612
MBX Biosciences
MBX
$1.67B
$1.49M 0.01%
+85,000
APAD
613
A Paradise Acquisition Corp
APAD
$1.42B
$1.49M 0.01%
+150,000
OTIS icon
614
Otis Worldwide
OTIS
$36.2B
$1.46M 0.01%
15,920
-20,169
MRNA icon
615
Moderna
MRNA
$19.4B
$1.42M 0.01%
55,000
-20,000
STLD icon
616
Steel Dynamics
STLD
$27.8B
$1.41M 0.01%
10,089
-19,966
ITT icon
617
ITT
ITT
$17.6B
$1.37M 0.01%
7,665
-17,773
GILD icon
618
Gilead Sciences
GILD
$187B
$1.33M 0.01%
12,014
-12,411
CHRS icon
619
Coherus Oncology
CHRS
$207M
$1.33M 0.01%
810,000
-25,000
DXLG icon
620
Destination XL Group
DXLG
$31.6M
$1.31M 0.01%
1,000,004
KYMR icon
621
Kymera Therapeutics
KYMR
$6.92B
$1.31M 0.01%
23,134
+18,134
MTRX icon
622
Matrix Service
MTRX
$313M
$1.31M 0.01%
+100,000
RNA icon
623
Avidity Biosciences
RNA
$11.3B
$1.31M 0.01%
30,000
-45,000
LRMR icon
624
Larimar Therapeutics
LRMR
$258M
$1.3M 0.01%
403,449
+174,688
NUVL icon
625
Nuvalent
NUVL
$8.08B
$1.3M 0.01%
+15,000
23 24
25
26 27